|
Markt geschlossen -
NYSE
22:00:02 28.08.2026
|
% 5 Tage | Veränd. 1. Jan. | ||
| 162.70 USD | -1.11% |
|
-1.98% | +76.98% |
| 28.08. | Jefferies belässt Astrazeneca auf 'Buy' - Ziel 17500 Pence | DP |
| 28.08. | AstraZeneca zeigt positive Phase-III-Ergebnisse für Tezspire bei eosinophiler Ösophagitis | CI |
ETFs investiert in AstraZeneca PLC
| Name | % 1. Jan. | Gewichtung | Volumen | |
|---|---|---|---|---|
 | +16.62% | -.--% | 334 922 M€ | |
| +14.99% | -.--% | 2 210 M€ | |
| +10.21% | -.--% | 1 193 M€ | |
| +18.26% | -.--% | 1 646 M€ | |
| +6.91% | 4.85% | 5 M€ | |
| +24.91% | 4.05% | 81 M€ | |
| +6.54% | 3.39% | 94 M€ | |
| +13.57% | 1.83% | 331 M€ | |
| +22.56% | 1.5% | 210 M€ | |
| +16.26% | 1.29% | 1 882 M€ | |
| +18.59% | 1.15% | 19 M€ | |
| +11.68% | 1.12% | 6 576 M€ | |
| +20.82% | 1.06% | 122 M€ | |
| +11.74% | 1% | 13 M€ | |
| +9.86% | 0.62% | 8 M€ | |
| +11.48% | 0.54% | 361 M€ | |
| +9.59% | 0.42% | 8 285 M€ | |
| +7.68% | 0.31% | 5 369 M€ | |
| +13.95% | 0.3% | 630 M€ | |
| +19.59% | 0.3% | 2 914 M€ | |
| -5.15% | 0.3% | 15 M€ | |
| +17.91% | 0.3% | 38 M€ | |
| +15.84% | 0.3% | 100 M€ | |
| +14.81% | 0.3% | 16 M€ | |
| +18.36% | 0.29% | 40 M€ | |
| +18.22% | 0.29% | 115 M€ | |
| +17.98% | 0.29% | 138 M€ | |
| +1.24% | 0.28% | 13 961 M€ | |
| +17.06% | 0.27% | 6 226 M€ |
Beschäftigte
96’100
Sektor
Pharmazeutika
Termine
- Börse
- Aktien
- 886455 Aktie
- 886715 Aktie
- ETFs AstraZeneca PLC
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
